drugset / Trial / NCT00123162

Viagra in the Treatment of Primary Dysmenorrhea

NCT00123162

RandomizedParallel-groupSingle-blindTreatment

Summary

The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.

Timeline

Start
2007-05
Primary completion
2011-06
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Other

Indications